Cargando…

Clinical experience with antifibrotics in fibrotic hypersensitivity pneumonitis: a 3-year real-life observational study

BACKGROUND: Fibrotic hypersensitivity pneumonitis (f-HP) can exhibit a progressive course similar to idiopathic pulmonary fibrosis (IPF). The lack of diagnostic guidelines and randomised controlled trials in this population represent a significant unmet need. OBJECTIVES: To describe our clinical exp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tzilas, Vasilios, Tzouvelekis, Argyris, Bouros, Evangelos, Karampitsakos, Theodoros, Ntassiou, Maria, Avdoula, Eleni, Trachalaki, Athena, Antoniou, Katerina, Raghu, Ganesh, Bouros, Demosthenes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682660/ https://www.ncbi.nlm.nih.gov/pubmed/33263028 http://dx.doi.org/10.1183/23120541.00152-2020

Ejemplares similares

Impact of Depression on Patients With Idiopathic Pulmonary Fibrosis
por: Tzouvelekis, Argyris, et al.
Publicado: (2020)

Telomeropathy in Chronic Hypersensitivity Pneumonitis
por: Bouros, Demosthenes, et al.
Publicado: (2019)

The Role of Hydroxychloroquine in Coronavirus Disease 2019. A Versatile Tool at the Service of Humanity
por: Tzouvelekis, Argyris, et al.
Publicado: (2020)

Endotyping of progressive fibrotic interstitial lung diseases: It is the final destination that matters and not the journey
por: Tzouvelekis, Argyris, et al.
Publicado: (2020)

Diagnosis of Idiopathic Pulmonary Fibrosis “Pragmatic Challenges in Clinical Practice”
por: Tzilas, Vasilios, et al.
Publicado: (2017)

The Role of Microbiome and Virome in Idiopathic Pulmonary Fibrosis
por: Ntolios, Paschalis, et al.
Publicado: (2021)

Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece
por: Tzouvelekis, Argyrios, et al.
Publicado: (2017)

Corrigendum: Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece
por: Tzouvelekis, Argyrios, et al.
Publicado: (2018)

Biologic Treatments in Interstitial Lung Diseases
por: Karampitsakos, Theodoros, et al.
Publicado: (2019)

False Positive COVID-19 Antibody Test in a Case of Granulomatosis With Polyangiitis
por: Tzouvelekis, Argyrios, et al.
Publicado: (2020)

Cystic lung disease in Birt-Hogg-Dubé syndrome. A case series
por: Tzilas, Vasilios, et al.
Publicado: (2020)

Update on COVID-19: A teleconference with the Paediatric Virology Study Group (Review)
por: Tzilas, Vasilios, et al.
Publicado: (2020)

Estrogen Signaling and MicroRNAs in Lung Fibrosis. Sex, Hormones, and Rock Scars
por: Tzouvelekis, Argyris, et al.
Publicado: (2019)

Metabolic Disorders in Chronic Lung Diseases
por: Papaioannou, Ourania, et al.
Publicado: (2018)

Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study
por: Antoniou, Katerina, et al.
Publicado: (2020)

Angiogenesis in Interstitial Lung Diseases: a pathogenetic hallmark or a bystander?
por: Tzouvelekis, Argyris, et al.
Publicado: (2006)

Application of microarray technology in pulmonary diseases
por: Tzouvelekis, Argyris, et al.
Publicado: (2004)

Serum biomarkers in Acute Respiratory Distress Syndrome an ailing prognosticator
por: Tzouvelekis, Argyris, et al.
Publicado: (2005)

Formoterol in the management of chronic obstructive pulmonary disease
por: Steiropoulos, Paschalis, et al.
Publicado: (2008)

Effect and Safety of Mycophenolate Mofetil in Idiopathic Pulmonary Fibrosis
por: Tzouvelekis, Argyris, et al.
Publicado: (2011)

Serum biomarkers in interstitial lung diseases
por: Tzouvelekis, Argyris, et al.
Publicado: (2005)

Effect and Safety of Mycophenolate Mofetil or Sodium in Systemic Sclerosis-Associated Interstitial Lung Disease: A Meta-Analysis
por: Tzouvelekis, Argyris, et al.
Publicado: (2012)

Use of interrupter technique in assessment of bronchial responsiveness in normal subjects
por: Panagou, Panagiotis, et al.
Publicado: (2004)

Lung Cancer and Interstitial Lung Diseases: A Systematic Review
por: Archontogeorgis, Kostas, et al.
Publicado: (2012)

Crazy paving pattern as a rare radiological manifestation of peripheral T-cell lymphoma (PTCL) with lung involvement: A case report
por: Gomatou, Georgia, et al.
Publicado: (2018)

Mesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis
por: Tzouvelekis, Argyrios, et al.
Publicado: (2018)

The DIAMORFOSIS (DIAgnosis and Management Of lung canceR and FibrOSIS) survey: international survey and call for consensus
por: Tzouvelekis, Argyris, et al.
Publicado: (2021)

A Rare Case of Primary Intrapulmonary Neurilemmoma Diagnosed in a 43-Year-Old Asymptomatic Man with a Well-defined Intrapulmonary Mass
por: Chrysikos, Serafeim, et al.
Publicado: (2018)

Clusters of comorbidities in fibrotic hypersensitivity pneumonitis
por: Prior, Thomas Skovhus, et al.
Publicado: (2022)

Increased Red Cell Distribution Width Is Associated With Disease Severity in Hospitalized Adults With SARS-CoV-2 Infection: An Observational Multicentric Study
por: Karampitsakos, Theodoros, et al.
Publicado: (2020)

Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis
por: Collins, Bridget F., et al.
Publicado: (2019)

SH2 Domain-Containing Phosphatase-SHP2 Attenuates Fibrotic Responses through Negative Regulation of Mitochondrial Metabolism in Lung Fibroblasts
por: Karampitsakos, Theodoros, et al.
Publicado: (2023)

Clinical characteristics of hypersensitivity pneumonitis: non-fibrotic and fibrotic subtypes
por: Chen, Xueying, et al.
Publicado: (2023)

HbA(1c) is associated with severity of obstructive sleep apnea hypopnea syndrome in nondiabetic men
por: Papanas, Nikolaos, et al.
Publicado: (2009)

Acute effect of smoking on plasma Obestatin levels
por: Kukuvitis, Asterios, et al.
Publicado: (2010)

Stem cell therapy for idiopathic pulmonary fibrosis: a protocol proposal
por: Tzouvelekis, Argyris, et al.
Publicado: (2011)

Addition of antifibrotic therapy to immunosuppression in hypersensitivity pneumonitis: A case series
por: Kypreos, Margaret, et al.
Publicado: (2021)

A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis
por: Tzouvelekis, Argyris, et al.
Publicado: (2013)

Fibrotic Hypersensitivity Pneumonitis: Key Issues in Diagnosis and Management
por: Kouranos, Vasileios, et al.
Publicado: (2017)

Antigen avoidance and outcome of nonfibrotic and fibrotic hypersensitivity pneumonitis
por: Nishida, Takashi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d18npvi963mmqi9qj2q7socrce